GLP-1s may alleviate depression through the microbiome, mouse study suggests

GLP-1s may alleviate depression through the microbiome, mouse study suggests

Some people taking GLP-1 drugs for diabetes and obesity experience mental health benefits—particularly a decrease in symptoms of depression. In a mouse model study published in Cell Host & Microbe, researchers report that these mental health improvements appear to result from changes in the gut microbiome that lead to an abundance of a microbial strain known to have a favorable effect on neurons related to stress.